CN113382742A - 工程化的鞭毛蛋白来源的组合物和用途 - Google Patents
工程化的鞭毛蛋白来源的组合物和用途 Download PDFInfo
- Publication number
- CN113382742A CN113382742A CN201980090594.0A CN201980090594A CN113382742A CN 113382742 A CN113382742 A CN 113382742A CN 201980090594 A CN201980090594 A CN 201980090594A CN 113382742 A CN113382742 A CN 113382742A
- Authority
- CN
- China
- Prior art keywords
- amino acid
- flagellin
- flagellin variant
- seq
- hydrophilic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/255—Salmonella (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0275—Salmonella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55516—Proteins; Peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
- A61K2039/585—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation wherein the target is cancer
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Toxicology (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862776507P | 2018-12-07 | 2018-12-07 | |
| US62/776,507 | 2018-12-07 | ||
| PCT/US2019/064954 WO2020118192A1 (en) | 2018-12-07 | 2019-12-06 | Engineered flagellin-derived compositions and uses |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN113382742A true CN113382742A (zh) | 2021-09-10 |
Family
ID=70974397
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201980090594.0A Pending CN113382742A (zh) | 2018-12-07 | 2019-12-06 | 工程化的鞭毛蛋白来源的组合物和用途 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20220024991A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3890769A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2022511881A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20210111770A (cg-RX-API-DMAC7.html) |
| CN (1) | CN113382742A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2019392903A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3122067A1 (cg-RX-API-DMAC7.html) |
| EA (1) | EA202191610A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL283757A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020118192A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102720967B1 (ko) * | 2020-06-04 | 2024-10-23 | 가톨릭대학교 산학협력단 | 플라젤린으로부터 유도된 tlr5 작용제를 유효성분으로 포함하는 면역관문억제제의 항암 효과 증진용 약학 조성물 |
| CN119522108A (zh) * | 2022-06-01 | 2025-02-25 | 弗莱格生物公司 | Rna佐剂、其方法和用途 |
| KR102896818B1 (ko) * | 2022-10-19 | 2025-12-08 | 전남대학교 산학협력단 | Tlr5 활성능을 가진 플라젤린 면역증강제 유도체의 진핵세포 발현시스템을 이용한 제조 및 응용 |
| KR20240081501A (ko) * | 2022-11-14 | 2024-06-10 | 전남대학교산학협력단 | 암의 치료용 면역증강 살모넬라 균주 및 이의 용도 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2121734B1 (en) * | 2007-02-09 | 2013-05-08 | Industry Foundation of Chonam National University | Modified flagellin improved toll-like receptor 5 stimulating activity |
| US9376495B2 (en) * | 2011-05-21 | 2016-06-28 | Macrogenics, Inc. | Deimmunized serum-binding domains and their use in extending serum half-life |
| CA2903252C (en) * | 2013-03-14 | 2023-01-17 | Research Corporation Technologies, Inc. | Ribotoxin molecules derived from sarcin and other related fungal ribotoxins |
| EP3174893B1 (en) * | 2014-07-30 | 2020-05-06 | Genome Protection, Inc. | Flagellin compositions and uses |
-
2019
- 2019-12-06 EA EA202191610A patent/EA202191610A1/ru unknown
- 2019-12-06 EP EP19892798.0A patent/EP3890769A4/en not_active Withdrawn
- 2019-12-06 CN CN201980090594.0A patent/CN113382742A/zh active Pending
- 2019-12-06 US US17/299,373 patent/US20220024991A1/en not_active Abandoned
- 2019-12-06 CA CA3122067A patent/CA3122067A1/en active Pending
- 2019-12-06 WO PCT/US2019/064954 patent/WO2020118192A1/en not_active Ceased
- 2019-12-06 JP JP2021532369A patent/JP2022511881A/ja active Pending
- 2019-12-06 AU AU2019392903A patent/AU2019392903A1/en not_active Abandoned
- 2019-12-06 KR KR1020217021065A patent/KR20210111770A/ko not_active Ceased
-
2021
- 2021-06-06 IL IL283757A patent/IL283757A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA3122067A1 (en) | 2020-06-11 |
| US20220024991A1 (en) | 2022-01-27 |
| IL283757A (en) | 2021-07-29 |
| EA202191610A1 (ru) | 2021-10-25 |
| AU2019392903A1 (en) | 2021-06-24 |
| JP2022511881A (ja) | 2022-02-01 |
| EP3890769A4 (en) | 2022-11-23 |
| EP3890769A1 (en) | 2021-10-13 |
| KR20210111770A (ko) | 2021-09-13 |
| WO2020118192A1 (en) | 2020-06-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11034733B2 (en) | Flagellin compositions and uses | |
| CN110536703B (zh) | 使用抗axl抗体-药物缀合物的组合疗法 | |
| CN113164589A (zh) | 用于调节单核细胞和巨噬细胞发炎表型的组合物和方法以及其免疫疗法用途 | |
| US20220111065A1 (en) | Molecular adjuvant | |
| JP2020517652A5 (cg-RX-API-DMAC7.html) | ||
| US20220024991A1 (en) | Engineered flagellin-derived compositions and uses | |
| AU2016318136A1 (en) | Selection of patients for combination therapy | |
| WO2016014899A1 (en) | Flagellin derivatives and uses | |
| US20250145715A1 (en) | B7-h3 targeting fusion proteins and methods of use thereof | |
| JP2025179057A (ja) | 併用療法のための患者の選択 | |
| EP4351618A2 (en) | Trem-2/dap-12 inhibitors for treating lung disease and injury and combinations thereof | |
| HK1237803A1 (en) | Flagellin compositions and uses | |
| HK1237803B (en) | Flagellin compositions and uses | |
| HK40050163A (en) | Selection of patients for combination therapy | |
| HK40050163B (en) | Selection of patients for combination therapy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20210910 |